Cytotherapy Market - Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: CB7BD8142F28EN
Market Monitor Global

Abstracts

Cytotherapy is a therapy in which viable cells are injected, grafted or implanted into a patient in order to effectuate a medicinal effect, for example, by transplanting T-cells capable of fighting cancer cells via cell-mediated immunity in the course of immunotherapy, or grafting stem cells to regenerate diseased tissues.

This report contains market size and forecasts of Cytotherapy in Global, including the following market information:

Global Cytotherapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cytotherapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Stem Cell Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cytotherapy include Gilead Sciences, Novartis, Osiris, Vericel Corporation, Vcanbio, Fujifilm Cellular Dynamics, JCR Pharmaceuticals, Beike Biotechnology and Golden Meditech and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytotherapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cytotherapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cytotherapy Market Segment Percentages, by Type, 2021 (%)

• Stem Cell
• Non-Stem Cell

Global Cytotherapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cytotherapy Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Others

Global Cytotherapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cytotherapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cytotherapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cytotherapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences
• Novartis
• Osiris
• Vericel Corporation
• Vcanbio
• Fujifilm Cellular Dynamics
• JCR Pharmaceuticals
• Beike Biotechnology
• Golden Meditech
• Guanhao Biotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cytotherapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cytotherapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CYTOTHERAPY OVERALL MARKET SIZE

2.1 Global Cytotherapy Market Size: 2021 VS 2028
2.2 Global Cytotherapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cytotherapy Players in Global Market
3.2 Top Global Cytotherapy Companies Ranked by Revenue
3.3 Global Cytotherapy Revenue by Companies
3.4 Top 3 and Top 5 Cytotherapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cytotherapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cytotherapy Players in Global Market
  3.6.1 List of Global Tier 1 Cytotherapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cytotherapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cytotherapy Market Size Markets, 2021 & 2028
  4.1.2 Stem Cell
  4.1.3 Non-Stem Cell
4.2 By Type - Global Cytotherapy Revenue & Forecasts
  4.2.1 By Type - Global Cytotherapy Revenue, 2017-2022
  4.2.2 By Type - Global Cytotherapy Revenue, 2023-2028
  4.2.3 By Type - Global Cytotherapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cytotherapy Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Cytotherapy Revenue & Forecasts
  5.2.1 By Application - Global Cytotherapy Revenue, 2017-2022
  5.2.2 By Application - Global Cytotherapy Revenue, 2023-2028
  5.2.3 By Application - Global Cytotherapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cytotherapy Market Size, 2021 & 2028
6.2 By Region - Global Cytotherapy Revenue & Forecasts
  6.2.1 By Region - Global Cytotherapy Revenue, 2017-2022
  6.2.2 By Region - Global Cytotherapy Revenue, 2023-2028
  6.2.3 By Region - Global Cytotherapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cytotherapy Revenue, 2017-2028
  6.3.2 US Cytotherapy Market Size, 2017-2028
  6.3.3 Canada Cytotherapy Market Size, 2017-2028
  6.3.4 Mexico Cytotherapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cytotherapy Revenue, 2017-2028
  6.4.2 Germany Cytotherapy Market Size, 2017-2028
  6.4.3 France Cytotherapy Market Size, 2017-2028
  6.4.4 U.K. Cytotherapy Market Size, 2017-2028
  6.4.5 Italy Cytotherapy Market Size, 2017-2028
  6.4.6 Russia Cytotherapy Market Size, 2017-2028
  6.4.7 Nordic Countries Cytotherapy Market Size, 2017-2028
  6.4.8 Benelux Cytotherapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cytotherapy Revenue, 2017-2028
  6.5.2 China Cytotherapy Market Size, 2017-2028
  6.5.3 Japan Cytotherapy Market Size, 2017-2028
  6.5.4 South Korea Cytotherapy Market Size, 2017-2028
  6.5.5 Southeast Asia Cytotherapy Market Size, 2017-2028
  6.5.6 India Cytotherapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cytotherapy Revenue, 2017-2028
  6.6.2 Brazil Cytotherapy Market Size, 2017-2028
  6.6.3 Argentina Cytotherapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cytotherapy Revenue, 2017-2028
  6.7.2 Turkey Cytotherapy Market Size, 2017-2028
  6.7.3 Israel Cytotherapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Cytotherapy Market Size, 2017-2028
  6.7.5 UAE Cytotherapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Corporate Summary
  7.1.2 Gilead Sciences Business Overview
  7.1.3 Gilead Sciences Cytotherapy Major Product Offerings
  7.1.4 Gilead Sciences Cytotherapy Revenue in Global Market (2017-2022)
  7.1.5 Gilead Sciences Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Cytotherapy Major Product Offerings
  7.2.4 Novartis Cytotherapy Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Osiris
  7.3.1 Osiris Corporate Summary
  7.3.2 Osiris Business Overview
  7.3.3 Osiris Cytotherapy Major Product Offerings
  7.3.4 Osiris Cytotherapy Revenue in Global Market (2017-2022)
  7.3.5 Osiris Key News
7.4 Vericel Corporation
  7.4.1 Vericel Corporation Corporate Summary
  7.4.2 Vericel Corporation Business Overview
  7.4.3 Vericel Corporation Cytotherapy Major Product Offerings
  7.4.4 Vericel Corporation Cytotherapy Revenue in Global Market (2017-2022)
  7.4.5 Vericel Corporation Key News
7.5 Vcanbio
  7.5.1 Vcanbio Corporate Summary
  7.5.2 Vcanbio Business Overview
  7.5.3 Vcanbio Cytotherapy Major Product Offerings
  7.5.4 Vcanbio Cytotherapy Revenue in Global Market (2017-2022)
  7.5.5 Vcanbio Key News
7.6 Fujifilm Cellular Dynamics
  7.6.1 Fujifilm Cellular Dynamics Corporate Summary
  7.6.2 Fujifilm Cellular Dynamics Business Overview
  7.6.3 Fujifilm Cellular Dynamics Cytotherapy Major Product Offerings
  7.6.4 Fujifilm Cellular Dynamics Cytotherapy Revenue in Global Market (2017-2022)
  7.6.5 Fujifilm Cellular Dynamics Key News
7.7 JCR Pharmaceuticals
  7.7.1 JCR Pharmaceuticals Corporate Summary
  7.7.2 JCR Pharmaceuticals Business Overview
  7.7.3 JCR Pharmaceuticals Cytotherapy Major Product Offerings
  7.7.4 JCR Pharmaceuticals Cytotherapy Revenue in Global Market (2017-2022)
  7.7.5 JCR Pharmaceuticals Key News
7.8 Beike Biotechnology
  7.8.1 Beike Biotechnology Corporate Summary
  7.8.2 Beike Biotechnology Business Overview
  7.8.3 Beike Biotechnology Cytotherapy Major Product Offerings
  7.8.4 Beike Biotechnology Cytotherapy Revenue in Global Market (2017-2022)
  7.8.5 Beike Biotechnology Key News
7.9 Golden Meditech
  7.9.1 Golden Meditech Corporate Summary
  7.9.2 Golden Meditech Business Overview
  7.9.3 Golden Meditech Cytotherapy Major Product Offerings
  7.9.4 Golden Meditech Cytotherapy Revenue in Global Market (2017-2022)
  7.9.5 Golden Meditech Key News
7.10 Guanhao Biotech
  7.10.1 Guanhao Biotech Corporate Summary
  7.10.2 Guanhao Biotech Business Overview
  7.10.3 Guanhao Biotech Cytotherapy Major Product Offerings
  7.10.4 Guanhao Biotech Cytotherapy Revenue in Global Market (2017-2022)
  7.10.5 Guanhao Biotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cytotherapy Market Opportunities & Trends in Global Market
Table 2. Cytotherapy Market Drivers in Global Market
Table 3. Cytotherapy Market Restraints in Global Market
Table 4. Key Players of Cytotherapy in Global Market
Table 5. Top Cytotherapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cytotherapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cytotherapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cytotherapy Product Type
Table 9. List of Global Tier 1 Cytotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cytotherapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cytotherapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cytotherapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cytotherapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cytotherapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cytotherapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cytotherapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cytotherapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cytotherapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cytotherapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cytotherapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cytotherapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cytotherapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cytotherapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cytotherapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cytotherapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cytotherapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cytotherapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cytotherapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cytotherapy Revenue, (US$, Mn), 2023-2028
Table 30. Gilead Sciences Corporate Summary
Table 31. Gilead Sciences Cytotherapy Product Offerings
Table 32. Gilead Sciences Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Cytotherapy Product Offerings
Table 35. Novartis Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 36. Osiris Corporate Summary
Table 37. Osiris Cytotherapy Product Offerings
Table 38. Osiris Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 39. Vericel Corporation Corporate Summary
Table 40. Vericel Corporation Cytotherapy Product Offerings
Table 41. Vericel Corporation Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 42. Vcanbio Corporate Summary
Table 43. Vcanbio Cytotherapy Product Offerings
Table 44. Vcanbio Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 45. Fujifilm Cellular Dynamics Corporate Summary
Table 46. Fujifilm Cellular Dynamics Cytotherapy Product Offerings
Table 47. Fujifilm Cellular Dynamics Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 48. JCR Pharmaceuticals Corporate Summary
Table 49. JCR Pharmaceuticals Cytotherapy Product Offerings
Table 50. JCR Pharmaceuticals Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 51. Beike Biotechnology Corporate Summary
Table 52. Beike Biotechnology Cytotherapy Product Offerings
Table 53. Beike Biotechnology Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 54. Golden Meditech Corporate Summary
Table 55. Golden Meditech Cytotherapy Product Offerings
Table 56. Golden Meditech Cytotherapy Revenue (US$, Mn), (2017-2022)
Table 57. Guanhao Biotech Corporate Summary
Table 58. Guanhao Biotech Cytotherapy Product Offerings
Table 59. Guanhao Biotech Cytotherapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cytotherapy Segment by Type in 2021
Figure 2. Cytotherapy Segment by Application in 2021
Figure 3. Global Cytotherapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cytotherapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cytotherapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cytotherapy Revenue in 2021
Figure 8. By Type - Global Cytotherapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cytotherapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cytotherapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cytotherapy Revenue Market Share, 2017-2028
Figure 12. US Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cytotherapy Revenue Market Share, 2017-2028
Figure 16. Germany Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cytotherapy Revenue Market Share, 2017-2028
Figure 24. China Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cytotherapy Revenue Market Share, 2017-2028
Figure 30. Brazil Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cytotherapy Revenue Market Share, 2017-2028
Figure 33. Turkey Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cytotherapy Revenue, (US$, Mn), 2017-2028
Figure 37. Gilead Sciences Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Osiris Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Vericel Corporation Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vcanbio Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fujifilm Cellular Dynamics Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. JCR Pharmaceuticals Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Beike Biotechnology Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Golden Meditech Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Guanhao Biotech Cytotherapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)